• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毕罗Ⅱ式胃旁路手术后地诺单抗诱发的低钙血症

Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery.

作者信息

Schmucker Abigail M, Green Dina E, Montemuro Philip M

机构信息

Sidney Kimmel Medical College, Thomas Jefferson University, 1025 Walnut Street, Philadelphia, PA 19107, USA.

Lankenau Medical Center, 100 East Lancaster Avenue, Wynnewood, PA 19096, USA.

出版信息

Case Rep Endocrinol. 2020 Jul 23;2020:8833723. doi: 10.1155/2020/8833723. eCollection 2020.

DOI:10.1155/2020/8833723
PMID:32774945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7396013/
Abstract

Hypocalcemia is a known risk following bariatric surgery and can contribute to the development of osteoporosis. Osteoporosis is commonly treated with denosumab, though denosumab can exacerbate underlying abnormalities in calcium homeostasis. We present the case of a 59-year-old female with severe hypocalcemia who had been treated with denosumab for osteoporosis three months before and had Billroth II gastric bypass surgery 15 years before, for bariatric purposes. Intravenous calcium supplementation was used to correct the initial electrolyte abnormality, and the patient was able to maintain appropriate calcium levels on high doses of oral calcium before discharge. Denosumab-induced hypocalcemia has been previously reported in patients with predisposing conditions including chronic kidney disease, primary sclerosing cholangitis, Crohn's disease, and a history of sleeve gastrectomy for marginal gastric ulcers. A few cases of hypocalcemia have been reported in patients with a history of bariatric surgery secondary to vitamin D deficiency, but this report is unique in demonstrating denosumab-induced hypocalcemia after bariatric surgery with normal vitamin D levels, suggesting a primary malabsorption of calcium. The risk of severe hypocalcemia should be considered before initiating denosumab to treat osteoporosis in patients with a history of bariatric surgery. If denosumab is initiated, serum calcium levels should be closely monitored, and patients should be educated about the importance of adherence to calcium supplementation.

摘要

低钙血症是减肥手术后已知的风险,可导致骨质疏松症的发生。骨质疏松症通常用狄诺塞麦治疗,尽管狄诺塞麦会加剧钙稳态的潜在异常。我们报告一例59岁女性,患有严重低钙血症,她在三个月前因骨质疏松症接受了狄诺塞麦治疗,15年前因减肥目的接受了毕罗Ⅱ式胃旁路手术。静脉补钙用于纠正最初的电解质异常,患者在出院前能够通过高剂量口服钙剂维持适当的钙水平。先前已有报道,在患有包括慢性肾病、原发性硬化性胆管炎、克罗恩病以及因边缘性胃溃疡行袖状胃切除术病史等易感疾病的患者中,会发生狄诺塞麦诱导的低钙血症。有几例减肥手术史的患者因维生素D缺乏继发低钙血症的病例报告,但本报告的独特之处在于,展示了减肥手术后维生素D水平正常情况下发生的狄诺塞麦诱导的低钙血症,提示存在原发性钙吸收不良。对于有减肥手术史的患者,在开始使用狄诺塞麦治疗骨质疏松症之前,应考虑严重低钙血症的风险。如果开始使用狄诺塞麦,应密切监测血清钙水平,并应对患者进行关于坚持补钙重要性的教育。

相似文献

1
Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery.毕罗Ⅱ式胃旁路手术后地诺单抗诱发的低钙血症
Case Rep Endocrinol. 2020 Jul 23;2020:8833723. doi: 10.1155/2020/8833723. eCollection 2020.
2
Denosumab-induced hypocalcemia post bariatric surgery-a severe and protracted course: a case report.减重手术后导致的地舒单抗相关性低钙血症——严重且持久的病程:一例报告。
J Med Case Rep. 2023 Mar 2;17(1):73. doi: 10.1186/s13256-023-03764-w.
3
Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.地诺单抗治疗一名与原发性硬化性胆管炎相关的继发性骨质疏松症患者后出现严重低钙血症。
Endocr J. 2019 Mar 28;66(3):271-275. doi: 10.1507/endocrj.EJ18-0545. Epub 2019 Feb 2.
4
Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy.全胃切除术后单剂量地诺单抗治疗胃癌弥漫性骨转移后出现的持续性低钙血症
Intern Med. 2017 Nov 1;56(21):2879-2882. doi: 10.2169/internalmedicine.8908-17. Epub 2017 Sep 25.
5
Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?地舒单抗致骨质疏松症患者低钙血症:能否预知谁会发生低钙血症?
Osteoporos Int. 2020 Apr;31(4):655-665. doi: 10.1007/s00198-019-05261-7. Epub 2019 Dec 14.
6
SEVERE, PROLONGED, DENOSUMAB-INDUCED HYPOCALCEMIA WITH RECOVERY AFTER 111 DAYS OF HIGH-DOSE CALCIUM SUPPLEMENTATION.严重、长期的地诺单抗诱导的低钙血症,在高剂量补钙111天后恢复
AACE Clin Case Rep. 2019 Jan 30;5(1):e82-e85. doi: 10.4158/ACCR-2018-0295. eCollection 2019 Jan-Feb.
7
Hypocalcemia in Patients With Osteoporosis and Normal Renal Function, Treated With Denosumab, a Retrospective Analysis.骨质疏松且肾功能正常患者使用地诺单抗治疗后的低钙血症:一项回顾性分析
Nutr Metab Insights. 2024 Jan 8;17:11786388231223604. doi: 10.1177/11786388231223604. eCollection 2024.
8
Post-craniopharyngioma surgery hypocalcemia due to denosumab use for osteoporosis: A case report.去颅咽管瘤术后因使用地舒单抗治疗骨质疏松导致低钙血症:1 例报告。
Medicine (Baltimore). 2024 Sep 13;103(37):e39649. doi: 10.1097/MD.0000000000039649.
9
Hypocalcemia after thyroidectomy in patients with a history of bariatric surgery.有减肥手术史患者甲状腺切除术后的低钙血症
Surg Obes Relat Dis. 2017 Mar;13(3):484-490. doi: 10.1016/j.soard.2016.09.026. Epub 2016 Sep 28.
10
Previous gastric bypass surgery complicating total thyroidectomy.既往胃旁路手术使全甲状腺切除术复杂化。
Ear Nose Throat J. 2015 Mar;94(3):E12-6.

引用本文的文献

1
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.肠道、骨骼与肌肉:炎症性肠病中的骨肌减少三联征
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
2
Bone Response to Weight Loss Following Bariatric Surgery.减重手术后的骨反应。
Front Endocrinol (Lausanne). 2022 Jul 7;13:921353. doi: 10.3389/fendo.2022.921353. eCollection 2022.

本文引用的文献

1
The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia.钙的罪魁祸首:一例地诺单抗诱发的低钙血症病例。
Cureus. 2019 May 28;11(5):e4768. doi: 10.7759/cureus.4768.
2
Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.地诺单抗给药导致的严重症状性低钙血症:治疗与临床过程
Case Rep Nephrol Dial. 2019 Apr 23;9(1):33-41. doi: 10.1159/000499824. eCollection 2019 Jan-Apr.
3
Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature.地诺单抗治疗后一名透析患者出现严重低钙血症及甲状旁腺激素显著升高:病例报告及文献复习
Case Rep Nephrol. 2019 Mar 21;2019:3027419. doi: 10.1155/2019/3027419. eCollection 2019.
4
Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.地诺单抗治疗一名与原发性硬化性胆管炎相关的继发性骨质疏松症患者后出现严重低钙血症。
Endocr J. 2019 Mar 28;66(3):271-275. doi: 10.1507/endocrj.EJ18-0545. Epub 2019 Feb 2.
5
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease.地诺单抗诱导的慢性肾脏病严重低钙血症
Case Rep Nephrol. 2018 Nov 4;2018:7384763. doi: 10.1155/2018/7384763. eCollection 2018.
6
Osteoporosis: A Review of Treatment Options.骨质疏松症:治疗方案综述
P T. 2018 Feb;43(2):92-104.
7
Severe Hypocalcemia Following a Single Denosumab Injection.单次注射地诺单抗后发生严重低钙血症。
Isr Med Assoc J. 2017 Nov;19(11):719-721.
8
Hypocalcemia After Bariatric Surgery: Prevalence and Associated Risk Factors.减重手术后的低钙血症:患病率及相关危险因素
Obes Surg. 2017 Nov;27(11):2905-2911. doi: 10.1007/s11695-017-2705-7.
9
High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.高骨转换增加了绝经后骨质疏松症女性使用地诺单抗导致低钙血症的风险。
Ther Clin Risk Manag. 2016 Dec 5;12:1831-1840. doi: 10.2147/TCRM.S123172. eCollection 2016.
10
A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.RANKL的一个问题:地诺单抗诱导的低钙血症。
J Med Toxicol. 2016 Sep;12(3):305-8. doi: 10.1007/s13181-016-0543-y. Epub 2016 Mar 17.